Comment on: Safinamide as adjunctive therapy for Parkinson's disease: A promising option with room for improvement

被引：0
|
作者：
Matovu, Daniel [1 ]
机构：
[1] Kabale Univ, Dept Clin Pharmacol & Therapeut, Kabale, Uganda
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2024年 / 462卷
关键词：
MAO-B inhibitor; Wearing-off; Parkinson's disease; Safinamide;
D O I：
10.1016/j.jns.2024.123103
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Response to letter to editor 'comment on: Safinamide as adjunctive therapy for Parkinson's disease: A promising option with room for improvement'
    Nishikawa, Noriko
    Ishida, Takayuki
    Hatano, Taku
    Hattori, Nobutaka
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 462
  • [2] Emerging approaches in Parkinson's disease - adjunctive role of safinamide
    Mueller, Thomas
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1151 - 1160
  • [3] Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study
    Nishikawa, Noriko
    Hatano, Taku
    Nishioka, Kenya
    Ueno, Shin-Ichi
    Saiki, Shinji
    Nakamura, Ryota
    Yoritaka, Asako
    Ogawa, Takashi
    Shimo, Yasushi
    Sako, Wataru
    Shimura, Hideki
    Furukawa, Yoshiaki
    Kamei, Takanori
    Ishida, Takayuki
    Hattori, Nobutaka
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 461
  • [4] Safinamide in the treatment of Parkinson's disease
    Mueller, Thomas
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2020, 10 (04) : 195 - 204
  • [5] SAFINAMIDE FOR SYMPTOMS OF PARKINSON'S DISEASE
    Mueller, T.
    DRUGS OF TODAY, 2015, 51 (11) : 653 - 659
  • [6] Safinamide in the treatment of Parkinson's disease
    Schapira, Anthony H. V.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2261 - 2268
  • [7] Safinamide for the treatment of Parkinson's disease
    Dezsi, Livia
    Vecsei, Laszlo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 729 - 742
  • [8] Current status of safinamide for the drug portfolio of Parkinson's disease therapy
    Mueller, Thomas
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (09) : 969 - 977
  • [9] Clinical pharmacology review of safinamide for the treatment of Parkinson's disease
    Fabbri, Margherita
    Rosa, Mario M.
    Abreu, Daisy
    Ferreira, Joaquim J.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (06) : 481 - 496
  • [10] An expert opinion on safinamide in Parkinson's disease
    Onofrj, Marco
    Bonanni, Laura
    Thomas, Astrid
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (07) : 1115 - 1125
12345